Document Detail

A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
MedLine Citation:
PMID:  20456549     Owner:  NLM     Status:  In-Process    
BACKGROUND: Superficial basal cell carcinoma (sBCC) and Bowen's disease (BD) are usually slow-growing, low-grade malignancies that mainly affect older persons. Surgery is often the first choice of treatment and the modality with the lowest failure rate. However, non-invasive procedures, such as topical methyl aminolevulinate photodynamic therapy (MAL-PDT) and imiquimod, are increasingly demanded by dermatologists and patients, because of their generally favourable efficacy and adverse effects profile and their excellent cosmetic outcome.
OBJECTIVE: To assess the cost of MAL-PDT and of treatment with imiquimod for primary non-melanoma superficial cutaneous carcinomas compared with conventional surgery, thereby calculating the total medical cost, and the direct and indirect costs.
SETTING: We collected data on 67 patients with 86 tumours (32 sBCC, 54 BD). Patients were treated between May 2006 and April 2007 at the Dermatology Department of the Costa del Sol Hospital in Marbella, Spain. The mean cost and mean cost per complete clinical response were calculated for each therapeutic option.
RESULTS: After 2 years of follow-up, a complete response was observed in 89.5% of the MAL-PDT group, 87.5% of the imiquimod group and 97.5% of the surgery group. The difference in costs when compared with the surgery group was a mean saving per lesion treated of 307 euros for the imiquimod group, and 322 euros for the MAL-PDT group.
CONCLUSIONS: Although surgery proved to be more effective treatment, our results suggest that its average cost is greater than that of non-invasive therapy for the treatment of non-melanoma superficial cutaneous carcinomas on the lower limbs, at least after the first 2 years of follow-up.
M Aguilar; M de Troya; L Martin; N Benítez; M González
Related Documents :
10740339 - External cephalic version with epidural anaesthesia after failure of a first trial with...
10327229 - Cost-effectiveness of self-managed anticoagulant therapy in germany.
19839739 - Treatment of malignant pleural effusion: pleurx catheter or talc pleurodesis? a cost-ef...
21838909 - Repeated treatment of recurrent uncomplicated plasmodium falciparum malaria in senegal ...
22372589 - Improving prevention and treatment of venous thromboembolism: clinical trial results.
16148549 - Infliximab use in crohn's disease: impact on health care resources in the uk.
22456799 - Neurological recovery in patients of old healed tubercular rigid kyphosis with myelopat...
15108829 - Incidence of postdural puncture headache and backache, and success rate of dural punctu...
24560419 - Age alone should not preclude surgery: contemporary outcomes after aortic valve replace...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  24     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1431-6     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. Journal compilation © 2010 European Academy of Dermatology and Venereology.
Department of Dermatology, Hospital Costa del Sol, Marbella, España.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: st...
Next Document:  Allergic characteristics of urban schoolchildren with atopic eczema in Ghana.